MedTrace Logo

A Study Reviewing Medical Records of Adults With Helicobacter Pylori Infections in China

NCT05073367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23000

Last updated 2023-04-18

No results posted yet for this study

Summary

The main aim of the study is to review treatment therapies in people with Helicobacter pylori (H. pylori) infections in standard hospital settings in China.

In this study, the study doctors will review medical records of participants who have had H. pylori infections any time from 1st January 2019 to 31st December 2021. This study is about collecting existing data only; participants are not treated and do not need to visit a study doctor during this study.

Conditions

  • Helicobacter Pylori

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-21
Primary Completion
2023-04-12
Completion
2023-04-12

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05073367 on ClinicalTrials.gov